Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?
- PMID: 22016712
- PMCID: PMC3194113
- DOI: 10.3390/ijerph8093728
Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?
Abstract
The association of α-amino-β-methylaminopropionic acid (BMAA) with elevated incidence of amyotrophic lateral sclerosis/Parkinson's disease complex (ALS/PDC) was first identified on the island of Guam. BMAA has been shown to be produced across the cyanobacterial order and its detection has been reported in a variety of aquatic and terrestrial environments worldwide, suggesting that it is ubiquitous. Various in vivo studies on rats, mice, chicks and monkeys have shown that it can cause neurodegenerative symptoms such as ataxia and convulsions. Zebrafish research has also shown disruption to neural development after BMAA exposure. In vitro studies on mice, rats and leeches have shown that BMAA acts predominantly on motor neurons. Observed increases in the generation of reactive oxygen species (ROS) and Ca(2+) influx, coupled with disruption to mitochondrial activity and general neuronal death, indicate that the main mode of activity is via excitotoxic mechanisms. The current review pertaining to the neurotoxicity of BMAA clearly demonstrates its ability to adversely affect neural tissues, and implicates it as a potentially significant compound in the aetiology of neurodegenerative disease. When considering the potential adverse health effects upon exposure to this compound, further research to better understand the modes of toxicity of BMAA and the environmental exposure limits is essential.
Keywords: ALS; Alzheimer’s; BMAA; PDC; Parkinson’s; cyanobacteria; cycad; excitotoxicity; glia; neural; neurodegeneration; neuron; toxicology.
Figures



Similar articles
-
A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.J Toxicol Environ Health B Crit Rev. 2017;20(4):1-47. doi: 10.1080/10937404.2017.1297592. Epub 2017 Jun 9. J Toxicol Environ Health B Crit Rev. 2017. PMID: 28598725 Free PMC article. Review.
-
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.Amyotroph Lateral Scler. 2009;10 Suppl 2:7-20. doi: 10.3109/17482960903286009. Amyotroph Lateral Scler. 2009. PMID: 19929726
-
Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13380-3. doi: 10.1073/pnas.2235808100. Proc Natl Acad Sci U S A. 2003. PMID: 14612559 Free PMC article.
-
Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.Neurochem Int. 2007 Jun;50(7-8):998-1003. doi: 10.1016/j.neuint.2006.12.011. Epub 2007 Jan 14. Neurochem Int. 2007. PMID: 17296249 Review.
-
A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12228-31. doi: 10.1073/pnas.0404926101. Epub 2004 Aug 4. Proc Natl Acad Sci U S A. 2004. PMID: 15295100 Free PMC article.
Cited by
-
Analysis of β-N-methylamino-L-alanine (BMAA) in spirulina-containing supplements by liquid chromatography-tandem mass spectrometry.Aquat Biosyst. 2014 Aug 8;10:5. doi: 10.1186/2046-9063-10-5. eCollection 2014. Aquat Biosyst. 2014. PMID: 25120905 Free PMC article.
-
Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.Neurotox Res. 2018 Jan;33(1):62-75. doi: 10.1007/s12640-017-9790-1. Epub 2017 Aug 25. Neurotox Res. 2018. PMID: 28842862
-
Health-based cyanotoxin guideline values allow for cyanotoxin-based monitoring and efficient public health response to cyanobacterial blooms.Toxins (Basel). 2015 Feb 5;7(2):457-77. doi: 10.3390/toxins7020457. Toxins (Basel). 2015. PMID: 25664510 Free PMC article.
-
The Effects of Long-term, Low-dose β-N-methylamino-L-alanine (BMAA) Exposures in Adult SODG93R Transgenic Zebrafish.Neurotox Res. 2023 Oct;41(5):481-495. doi: 10.1007/s12640-023-00658-z. Epub 2023 Aug 8. Neurotox Res. 2023. PMID: 37552461 Free PMC article.
-
Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.Neurotox Res. 2022 Apr;40(2):614-635. doi: 10.1007/s12640-021-00455-6. Epub 2022 Jan 13. Neurotox Res. 2022. PMID: 35023054 Review.
References
-
- Arnold A, Edgren DC, Palladino VS. Amyotrophic lateral sclerosis; fifty cases observed on Guam. J Nerv Ment Dis. 1953;117:135–139. - PubMed
-
- Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution and special reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954;4:438–448. - PubMed
-
- Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954;4:355–378. - PubMed
-
- Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006;106:97–104. - PubMed
-
- Whiting MG. Food Practices in Als Foci in Japan, the Marianas, and New Guinea. Fed Proc. 1964;23:1343–1345. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous